CAP2 and Parkinson disease: In addition, we investigated whether the mRNA and protein expression of CAP2, SAP97, and ADAM10 are also affected in patients with neurodegenerative disorders such as Parkinson’s Disease (PD) and Alzheimer’s Disease (AD), which are also characterized by spine defects.